Paris-based Astraveus, which makes modular, microfluidic cell foundries for cell and gene therapy (CGT) manufacturing, completed an oversubscribed €16.5 million ($18.1 million) series seed ...

The French government awarded Astraveus, which makes modular, microfluidic cell foundries for cell and gene therapy (CGT) manufacturing, an $11 million grant as part of France’s “Innovation in ...

PARIS, June 27, 2023 /PRNewswire/ -- Astraveus SAS ("Astraveus" or the "Company"), the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT) manufacturing ...